What is NDC 33342-259?

33342-259 is the product NDC for oxcarbazepine, Oxcarbazepine 300 mg/5mL for suspension, listed with the FDA by Macleods Pharmaceuticals Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Macleods Pharmaceuticals Limited, NDC labeler code 33342. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for oxcarbazepine?

118 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

oxcarbazepine NDC 33342-259 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-259Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0259Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
33342-259-67	33342025967	1 BOTTLE in 1 CARTON (33342-259-67) / 250 mL in 1 BOTTLEMarketed from Jul 11, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): oxcarbazepine
Generic name (nonproprietary): oxcarbazepine
Active ingredients: Oxcarbazepine — 300 mg/5mL
Dosage form: For suspension
Route: Oral
Labeler: Macleods Pharmaceuticals LimitedNDC labeler code 33342
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207300
Marketing start: Jul 11, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 33342-259_962098cc-2d84-4723-a296-b110f1fd659eSPL ID 962098cc-2d84-4723-a296-b110f1fd659eSPL set ID 962098cc-2d84-4723-a296-b110f1fd659eRxCUI 283536UNII VZI5B1W380
Pharmacologic class: Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342025967 followed by a unit qualifier and the quantity

Package 33342-0259-67. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 29, 2025.

Indications (excerpt from the label)

Oxcarbazepine oral suspension, USP is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures. Oxcarbazepine oral suspension, USP is indicated for: • Adults: Monotherapy or adjunctive therapy in the treatment of partial-onset seizures • Pediatrics: - Monotherapy in the treatment of partial-onset seizures in children 4-16 years - Adjunctive therapy in the treatment of partial-onset seizures in children 2-16 years ( 1 )…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 33342-259

What is NDC 33342-259?: 33342-259 is the product NDC for oxcarbazepine, Oxcarbazepine 300 mg/5mL for suspension, listed with the FDA by Macleods Pharmaceuticals Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: oxcarbazepine.
What is the active ingredient?: Oxcarbazepine.
Who is the labeler?: Macleods Pharmaceuticals Limited, NDC labeler code 33342. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for oxcarbazepine?: 118 other product NDCs are listed under this name. See all oxcarbazepine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other oxcarbazepine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	Zameer Pharmaceuticals LLC	90096-173	90096-0173-01
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Zameer Pharmaceuticals LLC	90096-171	90096-0171-01
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Zameer Pharmaceuticals LLC	90096-172	90096-0172-01
Oxcarbazepine	Oxcarbazepine 300 mg/5mL	SuspensionOral	Novadoz Pharmaceuticals LLC	72205-354	72205-0354-85
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4664	70518-4664-0070518-4664-01
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4663	70518-4663-0070518-4663-01
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-2084	67046-2084-03
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0868	67046-0868-03
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0179	67046-0179-03
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7593	00904-7593-61

All 119 oxcarbazepine NDCs